Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Takayasu Arteritis | 2 | 2020 | 83 | 0.95 | Why? |
| Erdheim-Chester Disease | 1 | 2018 | 50 | 0.72 | Why? |
| Interleukin-1 | 2 | 2021 | 438 | 0.71 | Why? |
| Giant Cell Arteritis | 1 | 2020 | 137 | 0.70 | Why? |
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 88 | 0.66 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 1165 | 0.52 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.50 | Why? |
| Myocarditis | 2 | 2021 | 2731 | 0.31 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.22 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.22 | Why? |
| Fibromyalgia | 1 | 2021 | 174 | 0.18 | Why? |
| Behcet Syndrome | 1 | 2020 | 136 | 0.18 | Why? |
| Radionuclide Imaging | 1 | 2018 | 184 | 0.16 | Why? |
| Thalidomide | 1 | 2020 | 247 | 0.16 | Why? |
| Receptors, Interleukin-1 | 1 | 2018 | 161 | 0.16 | Why? |
| Mouth Mucosa | 1 | 2020 | 323 | 0.16 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.13 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.13 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.13 | Why? |
| Chest Pain | 1 | 2018 | 578 | 0.13 | Why? |
| Musculoskeletal Diseases | 1 | 2021 | 646 | 0.12 | Why? |
| Pericarditis | 1 | 2018 | 417 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.12 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2018 | 830 | 0.11 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.11 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Italy | 3 | 2020 | 38444 | 0.05 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.05 | Why? |
| Oral Ulcer | 1 | 2020 | 70 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Male | 6 | 2021 | 367725 | 0.04 | Why? |
| Methotrexate | 1 | 2021 | 471 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Humans | 9 | 2021 | 930598 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.02 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |